Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Enliven Therapeutics is a clinical-stage biopharmaceutical company developing small molecule therapeutics targeting validated cancer drivers. Its focus includes precision oncology treatments for conditions like chronic myeloid leukemia and HER2-driven cancers. The company leverages differentiated chemistry and validated biology to create targeted, tolerable therapies aimed at overcoming resistance and improving patient outcomes across global markets.
This description was generated via AI from an annual report. Updated about 1 year ago.